Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Obstet Gynecol 133:E78E89
Compound Overview Class of Compound: Peptide Mechanism of Action: PT-141 is an agonist of the melanocortin receptors, with high affinity for MC4R, the stimulation of which increases sexual desire and causes sexual arousal in both men and women Notable Studies: Also Known As: Bremelanotide, bremelanotide acetate, Rekynda, Vyleesi, CID9941379 Research Applications: Sexual funtion Male sexual arousal Anti-inflammatory action Risks: Injection-related side effects Temporarily increases blood pressure Not FDA approved to treat men
Sperm DNA fragmentation: a new guideline for clinicians
4 Clinical evidence In adults with obesity, 72 weeks of orforglipron treatment resulted in greater body-weight reductions than placebo, up to -11.2%, compared to -2.1% with placebo
Next generation weight loss drugs for the prevention of cancer
US$ 28.46
US$ 21.48
US$ 24.65
